Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Regulus Therapeutics Stock News

RGLSNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$1.69

-0.11-6.39%

At close: -

$1.73

0.042.67%

After Hours: Apr 4, 9:16 AM EDT

Regulus Therapeutics (RGLS) Forecast

News

Earnings Regulus Therapeutics (RGLS) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest Regulus Therapeutics Stock News | NASDAQ:RGLS | Benzinga

Get the latest news on Regulus Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Regulus Therapeutics performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, March 27, 2025

Wells Fargo Upgrades Regulus Therapeutics to ...
Benzinga Newsdesk - Mar 27, 2025, 2:06PM
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights - Mar 27, 2025, 1:05PM
Regulus Therapeutics Stock Shoots Higher After Positive Results From Investigational Drug For Rare Type Of Kidney Disease
Vandana Singh - Mar 27, 2025, 12:59PM
Regulus Therapeutics shares are trading highe...
Benzinga Newsdesk - Mar 27, 2025, 8:25AM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Mar 27, 2025, 8:05AM
Regulus Therapeutics Announced Topline Result...
Benzinga Newsdesk - Mar 27, 2025, 7:02AM

Monday, March 17, 2025

Canaccord Genuity Maintains Buy on Regulus Th...
Benzinga Newsdesk - Mar 17, 2025, 11:37AM

Friday, March 14, 2025

HC Wainwright & Co. Reiterates Buy on Regulus...
Benzinga Newsdesk - Mar 14, 2025, 6:56AM

Thursday, March 13, 2025

Regulus Therapeutics Q4 2024 GAAP EPS $(0.20)...
Benzinga Newsdesk - Mar 13, 2025, 4:15PM

Wednesday, February 26, 2025

HC Wainwright & Co. Reiterates Buy on Regulus...
Benzinga Newsdesk - Feb 26, 2025, 7:55AM

Wednesday, January 29, 2025

Regulus Therapeutics shares are trading highe...
Benzinga Newsdesk - Jan 29, 2025, 7:26AM
Regulus Therapeutics Announced Positive Clini...
Benzinga Newsdesk - Jan 29, 2025, 7:12AM

Monday, November 11, 2024

HC Wainwright & Co. Reiterates Buy on Regulus...
Benzinga Newsdesk - Nov 11, 2024, 7:27AM

Thursday, November 07, 2024

Regulus Therapeutics Q3 EPS $(0.21) Misses $(...
Benzinga Newsdesk - Nov 7, 2024, 5:00PM

Wednesday, October 30, 2024

HC Wainwright & Co. Reiterates Buy on Regulus...
Benzinga Newsdesk - Oct 30, 2024, 8:21AM

Monday, October 28, 2024

Watching Regulus Therapeutics, Ventyx Bioscie...
Benzinga Newsdesk - Oct 28, 2024, 11:22AM

Tuesday, October 08, 2024

HC Wainwright & Co. Reiterates Buy on Regulus...
Benzinga Newsdesk - Oct 8, 2024, 3:29PM
Regulus Therapeutics Completes Enrollment Of ...
Benzinga Newsdesk - Oct 8, 2024, 8:03AM

Wednesday, August 14, 2024

Oppenheimer Reiterates Outperform on Regulus ...
Benzinga Newsdesk - Aug 14, 2024, 1:36PM

Friday, August 09, 2024

HC Wainwright & Co. Reiterates Buy on Regulus...
Benzinga Newsdesk - Aug 9, 2024, 5:26PM

Thursday, August 08, 2024

Regulus Therapeutics Q2 EPS $(0.17) Misses $(...
Benzinga Newsdesk - Aug 8, 2024, 5:34PM

Tuesday, July 16, 2024

HC Wainwright & Co. Reiterates Buy on Regulus...
Benzinga Newsdesk - Jul 16, 2024, 8:11AM

Tuesday, June 25, 2024

Canaccord Genuity Maintains Buy on Regulus Th...
Benzinga Newsdesk - Jun 25, 2024, 10:49AM
Ball To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Tuesday
Avi Kapoor - Jun 25, 2024, 7:27AM
HC Wainwright & Co. Maintains Buy on Regulus ...
Benzinga Newsdesk - Jun 25, 2024, 6:48AM

Monday, June 24, 2024

What's Going On With Regulus Therapeutics Stock Monday?
Dylan Berman - Jun 24, 2024, 11:32AM
Regulus Therapeutics shares are trading lower...
Benzinga Newsdesk - Jun 24, 2024, 11:17AM
Market-Moving News for June 24th
Benzinga Newsdesk - Jun 24, 2024, 8:39AM
Regulus Therapeutics shares are trading highe...
Benzinga Newsdesk - Jun 24, 2024, 7:43AM
Regulus Therapeutics Announces Results in Pha...
Benzinga Newsdesk - Jun 24, 2024, 7:10AM

Tuesday, June 04, 2024

Regulus Therapeutics Announces Expected Addit...
Benzinga Newsdesk - Jun 4, 2024, 8:13AM

Friday, May 31, 2024

Jones Trading Initiates Coverage On Regulus T...
Benzinga Newsdesk - May 31, 2024, 8:58AM

Wednesday, May 22, 2024

Bio-Techne And Regulus Therapeutics Announced...
Benzinga Newsdesk - May 22, 2024, 7:11AM

Friday, May 10, 2024

HC Wainwright & Co. Reiterates Buy on Regulus...
Benzinga Newsdesk - May 10, 2024, 7:51AM

Thursday, May 09, 2024

Regulus Therapeutics Q1 2024 GAAP EPS $(0.29)...
Benzinga Newsdesk - May 9, 2024, 5:36PM

Monday, May 06, 2024

12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights - May 6, 2024, 4:31PM
HC Wainwright & Co. Reiterates Buy on Regulus...
Benzinga Newsdesk - May 6, 2024, 2:02PM
Regulus Therapeutics Advances To Cohort 4 Of ...
Benzinga Newsdesk - May 6, 2024, 8:15AM

Monday, March 25, 2024

HC Wainwright & Co. Reiterates Buy on Regulus...
Benzinga Newsdesk - Mar 25, 2024, 6:16AM

Thursday, March 21, 2024

Regulus Therapeutics Q4 EPS $(0.40) Misses $(0.39) Estimate
Happy Mohamed - Mar 21, 2024, 4:08PM

Tuesday, March 19, 2024

Canaccord Genuity Maintains Buy on Regulus Th...
Benzinga Newsdesk - Mar 19, 2024, 8:12AM

Monday, March 18, 2024

Leerink Partners Initiates Coverage On Regulu...
Benzinga Newsdesk - Mar 18, 2024, 8:25AM
HC Wainwright & Co. Reiterates Buy on Regulus...
Benzinga Newsdesk - Mar 18, 2024, 7:01AM

Thursday, March 14, 2024

Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor - Mar 14, 2024, 1:38PM

Wednesday, March 13, 2024

Regulus Therapeutics shares are trading highe...
Benzinga Newsdesk - Mar 13, 2024, 1:58PM
Wells Fargo Maintains Equal-Weight on Regulus...
Benzinga Newsdesk - Mar 13, 2024, 6:53AM

Tuesday, March 12, 2024

Gold Down Over 1%; ClearOne Shares Spike Higher
Avi Kapoor - Mar 12, 2024, 2:57PM
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor - Mar 12, 2024, 2:07PM
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights - Mar 12, 2024, 1:31PM
Nasdaq Surges Over 1%; Blade Air Mobility Shares Plummet
Avi Kapoor - Mar 12, 2024, 12:10PM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved